antiviral farmasi

Upload: ari-puji-astuti

Post on 30-May-2018

225 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/9/2019 Antiviral Farmasi

    1/46

  • 8/9/2019 Antiviral Farmasi

    2/46

    UnderstandingViruses

    Viruses do not fit the moldfor a living organismRange size from 10-450nanometers

    Not grow unless cells wereadded to the growthmedium

    They cannot make anythingon their own, they use thecells materials to build

    themselvesOrigin: Speculated to berogue segments of DNAthat have taken a parasiticrole

  • 8/9/2019 Antiviral Farmasi

    3/46

    UnderstandingViruses

    The Capsid: A protein shell of capsomer subunits. It hasthree purposes: to Shield,Attach, and Penetrate

    The Envelope: Hybridcombination of cell lipids andvirus proteins, permitsattachment (note spikes)Nucleic Acids: Either DNA orRNA enclosed within the

    capsid that is later used toreplicate more viruses withinthe host cell

  • 8/9/2019 Antiviral Farmasi

    4/46

    Understanding Viruses

    Viral replication

    A virus cannot replicate on its own

    It must attach to and enter a host cell

    It then uses the host cells energy to synthesizeprotein, DNA, and RNA

  • 8/9/2019 Antiviral Farmasi

    5/46

  • 8/9/2019 Antiviral Farmasi

    6/46

    Understanding Viruses

    Viruses are difficult to kill becausethey live inside the cells

    Any drug that kills a virus may also kill cells

  • 8/9/2019 Antiviral Farmasi

    7/46

    Antivirals Drugs

    Viruses controlled by current antiviraltherapy

    Cytomegalovirus (CMV)Hepatitis virusesHerpes virusesHuman immunodeficiency virus (HIV)Influenza viruses (the flu)Respiratory syncytial virus (RSV)

  • 8/9/2019 Antiviral Farmasi

    8/46

    Antivirals DrugsCharacteristics of antiviral drugs

    Able to enter the cells infected with virus

    Interfere with viral nucleic acid synthesis and/or regulation

    Some drugs interfere with ability of virus to bind to cells

    Some drugs stimulate the bodys immune system

    Best responses to antiviral drugs are in patients withcompetent immune systems

    A healthy immune system works synergistically with thedrug to eliminate or suppress viral activity

  • 8/9/2019 Antiviral Farmasi

    9/46

    Antiviral Medications

    Antiviral drugsUsed to treat infections caused by viruses otherthan HIV

    Antiretroviral drugsUsed to treat infections caused by HIV, the virusthat causes AIDS

    Herpes-Simplex VirusesHSV-1 (oral herpes)HSV-2 (genital herpes)

    Varicella Zoster VirusChickenpoxShingles

  • 8/9/2019 Antiviral Farmasi

    10/46

    Antiviral Drugs:Nonretroviral

    Mechanism of actionInhibit viral replication

    Used to treat non-HIV viralinfections

    Influenza virusesHSV (herpes simplex virus), VZV (vericella zoster virus)CMV (cytomegalovirus)Hepatitis A, B, C (HAV, HBV, NCV)

    Adverse Effects

    Vary with each drugHealthy cells are often killed also, resulting in serioustoxicities

  • 8/9/2019 Antiviral Farmasi

    11/46

    Antivirals Drugs-NonretroviralAmantadine

    Narrow antiviral spectrum active only against influenza A

    Used prophylactically when vaccine is not available or cannotbe given

    Therapeutic use can reduce recovery time

    CNS effects : insomnia, nervousness, lightheadedness

    GI effects : anorexia, nausea, others

  • 8/9/2019 Antiviral Farmasi

    12/46

    Antivirals Drugs-NonretroviralRimantadine

    Same spectrum of activity, mechanismof action, and indications as amantadine

    Fewer CNS adverse effects

    Causes GI upset

  • 8/9/2019 Antiviral Farmasi

    13/46

    Antivirals Drugs-NonretroviralAcyclovir (Zovirax)

    Synthetic nucleoside analog

    Used to suppress replication of:HSV-1(oral herpes), HSV-2(genital herpes),VZV (Varicella chickenpox or shingles)

    Drug of choice for treatment of initial andrecurrent episodes of these infections

    Oral, topical, parenteral forms

  • 8/9/2019 Antiviral Farmasi

    14/46

  • 8/9/2019 Antiviral Farmasi

    15/46

    Antivirals Drugs-NonretroviralDose-Limiting Toxicities

    ganciclovir and zidovudineBone marrow toxicity

    foscarnet and cidofovirRenal toxicity

  • 8/9/2019 Antiviral Farmasi

    16/46

    Antivirals Drugs-NonretroviralNeuraminidase Inhibitors

    oseltamivir (Tamiflu) and zanamivir (Relenza)Active against influenza types A & B

    Use: Reduce duration of illness

    oseltamivir : causes nausea & vomiting

    zanamivir: causes diarrhea, nausea, sinusitis

    Treatment should begin within 2 days of

    influenza symptom onset

  • 8/9/2019 Antiviral Farmasi

    17/46

    Antivirals Drugs-NonretroviralRibavirin

    Synthetic nucleoside analog

    Given orally, or oral or nasal inhalation

    Inhalation form (Virazole) used for

    hospitalized infants with RSV (respiratorysyncytialvirus) infections

  • 8/9/2019 Antiviral Farmasi

    18/46

  • 8/9/2019 Antiviral Farmasi

    19/46

    HIVHuman immunodeficiency virus infection

    ELISA (enzyme-linked immunosorbent assay)Detects HIV exposure based on presence of human antibodies to the virus inthe blood

    RetrovirusTransmitted by:

    Sexual activity, intravenous drug use, perinatally from mother to child

    Five Stages of HIV Infection

    Stage 1: asymptomatic infectionStage 2 : early, general symptoms of diseaseStage 3 : moderate symptomsStage 4 : severe symptoms, often leading to death

    WHO model stages

  • 8/9/2019 Antiviral Farmasi

    20/46

  • 8/9/2019 Antiviral Farmasi

    21/46

    Antiretroviral Drugs

    Reverse transcriptase inhibitors (RTIs)Block activity of the enzyme reverse transcriptase,preventing production of new viral DNA

    Reverse transcriptase inhibitors (RTIs)Nucleoside RTIs (NRTIs)Nonnucleoside RTIs (NNRTIs)Nucleotide RTIs (NTRTIs)

    Examples

    abacavir (Ziagen) delavirdine (Rescriptor)didanosine (Videx) lamivudine (Epivir)stavudine (Zerit) tenofovir (Viread)

  • 8/9/2019 Antiviral Farmasi

    22/46

  • 8/9/2019 Antiviral Farmasi

    23/46

  • 8/9/2019 Antiviral Farmasi

    24/46

    Antiretroviral Drugs

    Fusion inhibitors

    Inhibit viral fusion, preventing viralreplication

    Newest class of antiretroviral drugs

    Example: enfuvirtide (Fuzeon)

  • 8/9/2019 Antiviral Farmasi

    25/46

    Antiretroviral Drugs

    Combinations of multipleantiretroviral medications are common

    Adverse effects vary with each drugand may be severe monitor for dose-limiting toxicities

    Monitor for signs of opportunisticdiseases

  • 8/9/2019 Antiviral Farmasi

    26/46

  • 8/9/2019 Antiviral Farmasi

    27/46

  • 8/9/2019 Antiviral Farmasi

    28/46

    Antiretroviral Drugs:Adverse Effects

    Numerousand vary with each drug

    Drug

    therapy may need to be modified because of adverse

    effects

    Goal is tofind the regimen that will best control the

    infection with a tolerable adverse effect profile

    Medication regimens change during the course of the illness

  • 8/9/2019 Antiviral Farmasi

    29/46

    Antifungal Agents

  • 8/9/2019 Antiviral Farmasi

    30/46

    Fungi (mycoses)

    Mild or life threateningWidely present in environmentDermatophytestinea capitis, tineapedis, tinea cruris, tinea corporisExamples: Candida, Aspergillosis,Cryptococcus, Histoplasmosis, B

  • 8/9/2019 Antiviral Farmasi

    31/46

    Antifungal Drugs

    Development of antifungals difficultbecause fungal cells closely resemblehuman cells

    PolyenesAmphotericin B, NystatinAzolesSporonox (itraconazole), Nizoral(ketoconazole), Diflucan (fluconazole)

    EchinocandinsEraxis (anidulafungin),Cancidas (caspofungin)

  • 8/9/2019 Antiviral Farmasi

    32/46

    Antifungal Drugs

    Drugs acting on fungi

    Block NucleicAcid Synthesis

    FLUCYTOSINGRISEOFUL

    VIN

    DISRUPTMICROTUBULE

    FUNCTION

    ALTER CELLMEMBRANE

    PERMEABILITY

    AZOLE,POLYENES,

    TERBINAFINE

  • 8/9/2019 Antiviral Farmasi

    33/46

  • 8/9/2019 Antiviral Farmasi

    34/46

    h (

  • 8/9/2019 Antiviral Farmasi

    35/46

    Amphotericin B ( POLYENEANTIBIOTIC)

    Poorly absorbed from G I tract.Mechanism of action: effect on permeability andtransport system of fungal membranes. Bin toergosterol formation artificial pores.Clinical use: Systemic mycosisAdverse effects:

    Infusion reaction with chills, fever, tachypnea Treat with Benadryl, Tylenol or steroids

    Nephrotoxicity most serious SE

  • 8/9/2019 Antiviral Farmasi

    36/46

    Amphotericin B

    Indicated for life-threatening fungalinfections such as aspergillosis,blastomycosis, candidiasis,

    coccinioidomycosis, crytococcis andhistoplasmosisDrug concentrations are highest ininflamed tissues

  • 8/9/2019 Antiviral Farmasi

    37/46

    Nystatin

    Same mechanism of action asAmphotericin B

    Too toxic for systemic use

  • 8/9/2019 Antiviral Farmasi

    38/46

    Miscellaneous Antifungals

    Lamisil (terbinafine)griseofulvin

  • 8/9/2019 Antiviral Farmasi

    39/46

    Azoles

    Largest group of commonly usedantifungalsCan be used topically or systemically

    Prototype is ketoconazoleFluconazole, itraconazole, VoriconazoleAll azoles are contraindicated in

    pregnancy

  • 8/9/2019 Antiviral Farmasi

    40/46

    Azoles

    Less toxic than amphoMany drug interactionsPoor absorption if achlorhydricSome hepatotoxicityCan be given orally

  • 8/9/2019 Antiviral Farmasi

    41/46

    fluconazole

    Synthetic, broad spectrum againstcandidiasis, cryptococcis,coccidioidomycosis

    Not effective against aspergillosisPO or IVFewer side effects than ketoconazole

    Does not require gastric acidity, does notcross blood-brain barrierReduce dosage in renal failure

  • 8/9/2019 Antiviral Farmasi

    42/46

    itraconazole

    Similar to Diflucan Drug of choice for blastomycosis,

    histoplasmosis and sporotrichosis

    Good for suppressive Tx in AIDS patientsw/histo Contraindicated for dermatophytic infections

    and onychomycoses in heart failure patients IV or PO Many drug interactions

  • 8/9/2019 Antiviral Farmasi

    43/46

    griseofulvin

    For dermatophyte infections of the scalpand nails and for extensive skineruptions

    Drug binds to keratin, over time theinfected tissues are shed and replacedby uninfected tissues

    Need 3-8 weeks to Tx ringwormUp to one year for onychomycoses

  • 8/9/2019 Antiviral Farmasi

    44/46

    terbinafine

    Synthetic with broad spectrum of activityInhibits an enzyme needed for synthesisof ergosterol, a structural component of

    fungal cell membranesGood for Tx of ringworm, nailshepatotoxic

    D T f S ifi

  • 8/9/2019 Antiviral Farmasi

    45/46

    Drug Treatment for SpecificInfections

    AspergillosisSporonox, Amphotericin BBlastomycosisSporonox, Amphotericin BCandidiasisvaries r/t area of infection

    OralCutaneousVaginal

    Systemic

    D T t t f F l

  • 8/9/2019 Antiviral Farmasi

    46/46

    Drug Treatment for FungalInfections

    HistoplasmosisSporanoxPCPBactrim, pentamidine, dapsone,others

    Cryptococcis-Amphotericin BCoccidioidomycosis- azole toAmphotericin B